Serum Lactate Dehydrogenase in Non-Hodgkin’s Lymphoma: A Prognostic Indicator

Charu Yadav, Afzal Ahmad, Benedicta D’Souza, Ashish Agarwal, M. Nandini, K. Ashok Prabhu, Vivian D’Souza

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)


Non-Hodgkin’s lymphoma constitutes a group of disorders originating from the malignant transformation of lymphocytes and involving either the lymph nodes or extranodal sites. NHL commonly presents in the sixth to seventh decade of life with a male preponderance (50–75 %). Recent studies have shown importance of serum LDH in prognosis of NHL. Authors report a case of a 63 year old male presenting with complaints of fever and backache for past 4 months. General and systemic examination revealed bilateral axillary lymphadenopathy and splenomegaly respectively. Serum LDH level was highly elevated (3441 U/l). Excisional axillary and bone marrow biopsy were done before oncology referral. Complete workup revealed diffuse Non-Hodgkin’s lymphoma with bone marrow infiltration. Patient died because of acute renal failure due to NHL and DM 2 (Type 2 diabetes mellitus).

Original languageEnglish
Pages (from-to)240-242
Number of pages3
JournalIndian Journal of Clinical Biochemistry
Issue number2
Publication statusPublished - 01-04-2016

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry


Dive into the research topics of 'Serum Lactate Dehydrogenase in Non-Hodgkin’s Lymphoma: A Prognostic Indicator'. Together they form a unique fingerprint.

Cite this